Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Beyondspring Inc (NQ: BYSI )

2.830 -0.010 (-0.35%)
Streaming Delayed Price Updated: 9:50 AM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Beyondspring Inc

< Previous 1 2 3 4 5 6 Next >
Mid-Morning Market Update: Markets Mostly Higher; Dollar General Posts Upbeat Q3 Earnings
Following the market opening Thursday, the Dow traded up 1.27% to 34,453.32 while the NASDAQ fell 0.01% to 15,252.20. The S&P also rose, gaining 0.76% to 4,547.40. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
10 Biggest Price Target Changes For Thursday
Wells Fargo boosted Five Below, Inc. (NASDAQ: FIVE) price target from $235 to $240. Five Below shares rose 10.5% to $209.00 in pre-market trading. Barclays boosted Snowflake... 
Via Benzinga
Why BeyondSpring Shares Are Diving Today
BeyondSpring Inc (NASDAQ: BYSI) is trading significantly lower Wednesday after the company announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug... 
Via Benzinga
Mid-Afternoon Market Update: Dow Rises Over 100 Points; CTI BioPharma Shares Plummet
Toward the end of trading Wednesday, the Dow traded up 0.39% to 34,617.2 while the NASDAQ climbed 0.17% to 15,564.73. The S&P also rose, gaining 0.68% to 4,597.96. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
61 Biggest Movers From Yesterday
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
ABUS Stock Alert: The Moderna News That Has Arbutus Biopharma Shares Rocketing Today
Arbutus Biopharma (ABUS) stock is taking off on Wednesday thanks to a court ruling in its favor in a case against Moderna (MRNA). 
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
BOX Stock: The Good News That Has Box, Inc. Shares Bounding Higher Today
Box (BOX) stock is on the rise Wednesday and it's thanks to the company's earnings report for the third quarter of fiscal 2022. 
Via InvestorPlace
iQIYI Layoffs: 10 Things for IQ Stock Investors to Know About the Massive Job Cuts
IQIYI (IQ) stock is on the move Wednesday following reports that the company is cutting a huge amount of its workforce in layoffs. 
Via InvestorPlace
BYSI Stock Alert: Bad News From the FDA Has BeyondSpring Tanking Today
BeyondSpring is falling hard after the FDA turned down a once-promising drug candidate. Here's why you shouldn't write off BYSI stock. 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Ardelyx (NASDAQ:ARDX) shares rose 25.87% to $1.44 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 215.1 million... 
Via Benzinga
Mid-Day Market Update: Build-A-Bear Jumps After Q3 Results; BeyondSpring Shares Slide
Midway through trading Wednesday, the Dow traded up 1.06% to 34,847.76 while the NASDAQ climbed 1.17% to 15,719.00. The S&P also rose, gaining 1.48% to 4,634.64. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) climbed 91.7% to $6.14 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down Moderna's... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Dow Eyes Triple-Digit Rebound to Kick Off Last Month of 2021
The Dow Jones Industrial Average was last seen up 379 points, working on recouping yesterday's dramatic losses. The S&P 500 and Nasdaq Composite are also kicking off the final month of 2021 with... 
Via Talk Markets
Topics Stocks
Exposures US Equities
BeyondSpring Shares Crater After FDA Rejects Plinabulin Application
The FDA has issued a Complete Response Letter to BeyondSpring Pharmaceuticals Inc's (NASDAQ: BYSI) marketing application seeking approval for plinabulin to... 
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; G-III Apparel Earnings Beat Views
Following the market opening Wednesday, the Dow traded up 0.99% to 34,824.47 while the NASDAQ climbed 1.40% to 15,755.57. The S&P also rose, gaining 1.39% to 4,630.57. The U.S... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers Skylight Health Group Inc. (NASDAQ: SLHG) rose 55.3% to $2.05 in pre-market trading after dipping around 10% on Tuesday. Skylight Health Group, last month, posted a... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Lannett (NYSE:LCI) shares rose 11.61... 
Via Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... 
Via Benzinga
Exposures Product Safety
20 Stocks Moving In Tuesday's Pre-Market Session
Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) rose 117.3% to $4.78 in pre-market trading after the company announced the FDA approved expanded labeling for Caldolor to... 
Via Benzinga
Exposures Product Safety
20 Stocks Moving in Monday's Pre-Market Session
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results... 
Via Benzinga
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, & More
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant helped mitigate the losses notched earlier in the holiday-shortened week. 
Via Talk Markets
Exposures COVID-19 Product Safety
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses... 
Via Benzinga
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6... 
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers XTL Biopharmaceuticals (NASDAQ:XTLB 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares in... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.